Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
Modern Pathology2006Vol. 19(4), pp. 514–523
Citations Over TimeTop 10% of 2006 papers
Hadi Yaziji, Hector Battifora, Todd Barry, Harry C. Hwang, Carlos E. Bacchi, Martin McIntosh, Steven J. Kussick, Allen M. Gown
Related Papers
- → Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma(2007)118 cited
- → Calretinin, thrombomodulin, CEA, and CD15: A useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma(2001)113 cited
- → Calretinin as a blood-based biomarker for mesothelioma(2017)44 cited
- → Use of mesothelin as a marker for mesothelial cells in cytologic specimens(2006)25 cited
- → Utility of a CEA, CD15, Calretinin, and CK5/6 Panel for Distinguishing Between Mesotheliomas and Pulmonary Adenocarcinomas in Clinical Practice(2012)16 cited